Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

Turn on more accessible mode

Turn off more accessible mode

Skip Ribbon Commands

Skip to main content

Turn off Animations

Turn on Animations

Terumo scientific programme at EuroPCR 2016

Terumo scientific programme at EuroPCR 2016

Symposium

Sharing solutions to frequent challenges in PCI strategies with complex anatomies and patients

Wednesday May 18, 2016, 16:30 - 18:00

Chairperson: Dr. Philip Urban
Co-Chairperson: Dr. Christian Spaulding

16:30 - 16:33	Session objectives Dr. Philip Urban
16:33 - 16:41	A challenging bifurcation case Dr. Antonio Colombo
16:41 - 16:49	Is there an alternative strategy? Dr. Julinda Mehilli
16:49 - 16:59	Discussion and audience interaction
16:59 - 17:01	Key learnings Dr. Philip Urban
17:01 - 17:09	A challenging STEMI patient Dr. Gennaro Sardella
17:09 - 17:17	Is there an alternative strategy? Dr. Cesar Moris
17:17 - 17:27	Discussion and audience interaction
17:27 - 17:29	Key learnings Dr. Christian Spaulding
17:29 - 17:37	A challenging high bleeding risk patient Dr. Marco Valgimigli
17:37 - 17:45	Is there an alternative strategy? Dr. Bernard Chevalier
17:45 - 17:55	Discussion and audience interaction
17:55 - 17:57	Key learnings Dr. Philip Urban
17:57 - 18:00	Session evaluation and key learnings Dr. Christian Spaulding

Are you a pharmaceutical professional?

This information is intended for professionals in the pharmaceutical supply chain who are interested in primary packaging, injection components and medical devices from Terumo Pharmaceutical Solutions, for use in combination with their respective drug products (hereafter, pharmaceutical professionals). Please note that the product information contained on this website is exclusively addressed to pharmaceutical professionals. This product information is not for the general public, nor is it intended to be a substitute for professional medical advice or for the care that patients receive from their healthcare professionals. By accessing it, you (i) acknowledge having read and understood both the above message and our terms of use and, further, (ii) confirm that you do so in the capacity of a pharmaceutical professional.